Next-generation antibiotic
- Protection for up to 7 days after the last injection
- Targeted action on the focus of inflammation
Reliable treatment
- Broad-spectrum action
- Overcomes resistance to old-generation of macrolide antibiotics, including tylosin and spiramycin
Next-generation drug
- Levofloxacin is a next-generation antibiotic
- Overcomes resistance to previous generations of fluoroquinolones
Effective and reliable treatment
- Stable to the development of resistance
- Ensures high livability, body weight gain and low feed conversion ratio
Protection against reinfection
- 7-day prolonged action
- 1-injection treatment course
Cost savings
- Economical consumption of the drug
High efficiency
- Maximum effectiveness in metaphylactic treatment
- High concentration in lungs
Long-lasting protection after 1 injection
- Treatment course is 1 injection
- Protection period for up to 15 days
